Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

 

Cannabidiol as a potential treatment for psychosis

 

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

 

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?

 

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

 

Peripheral endocannabinoid system dysregulation in first-episode psychosis

 

Cannabinoids and schizophrenia: Therapeutic prospects

 

Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies

 

Cannabidiol monotherapy for treatment-resistant schizophrenia

 

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

 

Marijuana compound treats schizophrenia with few side effects: Clinical trial

 

Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?